I tried breast cancer AI tools: The tech has substance, but one hurdle remains

Last week I met up with a team working on pathology AI, and their pitch really impressed me: they can map centrosome abnormalities onto entire tumor sections, showing defect differences across various regions. Centrosomes manage microtubule organization in cell biology; issues with them are linked to chromosomal instability and tumor heterogeneity. But previously, we could only count them one by one under high-magnification microscopy—no one was able to do a holistic analysis on whole tissue samples.